Human medicines European public assessment report (EPAR): Neoatricon, Dopamine hydrochloride, Date of authorisation: 27/05/2024, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 19 June 2024 - 11:05

Human medicines European public assessment report (EPAR): Neoatricon, Dopamine hydrochloride, Date of authorisation: 27/05/2024, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/neoatricon

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters